Privia Health Research and Development Expenses 2020-2024 | PRVA

Privia Health research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Privia Health Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
Privia Health Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31 $0
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.547B $1.658B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.384B 0.00
Inspire Medical Systems (INSP) United States $5.892B 183.76
Hims & Hers Health (HIMS) United States $5.028B 130.06
Axonics (AXNX) United States $3.600B 1760.50
IRhythm Technologies (IRTC) United States $2.707B 0.00
Enovis (ENOV) United States $2.594B 17.58
Omnicell (OMCL) United States $2.306B 75.97
Azenta (AZTA) United States $2.190B 124.39
10x Genomics (TXG) United States $1.893B 0.00
Clover Health Investments (CLOV) United States $1.696B 0.00
Schrodinger (SDGR) United States $1.365B 0.00
Phreesia (PHR) United States $1.228B 0.00
Standard BioTools (LAB) United States $0.800B 0.00
Fulgent Genetics (FLGT) United States $0.589B 0.00
Butterfly Network (BFLY) United States $0.558B 0.00
Talkspace (TALK) United States $0.555B 0.00
Definitive Healthcare (DH) United States $0.500B 84.80
Health Catalyst (HCAT) United States $0.498B 0.00
Pulmonx (LUNG) United States $0.294B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.230B 0.00
TruBridge (TBRG) United States $0.203B 58.91
American Well (AMWL) United States $0.135B 0.00
P3 Health Partners (PIII) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.108B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.059B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.045B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Outset Medical (OM) United States $0.040B 0.00
Movano (MOVE) United States $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00